Literature DB >> 2819748

Functional evidence for the presence of adenosine A2-receptors in cultured coronary endothelial cells.

C Des Rosiers, S Nees.   

Abstract

Adenosine and the adenosine receptor agonists, R- and S-N6-phenylisopropyladenosine (R- and S-PIA) and 5'-N-ethylcarboxamidoadenosine (NECA), enhanced [3H]cAMP accumulation in [3H]adenine-labelled cultured endothelial cells isolated from the microvasculature of guinea pig hearts. As shown by their concentration-response curves, NECA was a more potent agonist than R-PIA or adenosine. Their respective concentrations at half-maximal stimulation of [3H]cAMP accumulation were 0.7 microM, 10.5 microM and 12.6 microM, indicating a 15- to 18-fold potency difference between NECA and the other agonists. The increased [3H]cAMP accumulation elicited by 10(-5) M NECA was inhibited by the xanthine derivative 8-phenyltheophylline, 3-isobutyl-1-methylxanthine, theophylline or caffeine. These findings provide functional evidence for the presence of adenosine receptors of the A2-type in microvascular coronary endothelial cells in culture. The functional significance of these receptors remains to be established, but they may be involved in the regulation of vascular permeability.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2819748     DOI: 10.1007/BF00177757

Source DB:  PubMed          Journal:  Naunyn Schmiedebergs Arch Pharmacol        ISSN: 0028-1298            Impact factor:   3.000


  30 in total

1.  Morphological classifications of vertebrate blood capillaries.

Authors:  H S BENNETT; J H LUFT; J C HAMPTON
Journal:  Am J Physiol       Date:  1959-02

2.  Alkylxanthines: inhibition of adenosine-elicited accumulation of cyclic AMP in brain slices and of brain phosphodiesterase activity.

Authors:  F W Smellie; C W Davis; J W Daly; J N Wells
Journal:  Life Sci       Date:  1979-06-25       Impact factor: 5.037

3.  Characterization of a specific adenosine receptor on human lymphocytes.

Authors:  G Marone; M Plaut; L M Lichtenstein
Journal:  J Immunol       Date:  1978-12       Impact factor: 5.422

4.  Analogues of 4-(3,4-dimethoxybenzyl)-2-imidazolidinone as potent inhibitors of rat erythrocyte adenosine cyclic 3',5'-phosphate phosphodiesterase.

Authors:  H Sheppard; G Wiggan
Journal:  Mol Pharmacol       Date:  1971-01       Impact factor: 4.436

5.  Presence of "Ra" and "P"-site receptors for adenosine coupled to adenylate cyclase in cultured vascular smooth muscle cells.

Authors:  M B Anand-Srivastava; D J Franks; M Cantin; J Genest
Journal:  Biochem Biophys Res Commun       Date:  1982-09-16       Impact factor: 3.575

6.  Functional identification of adenylate cyclase-coupled adenosine receptors in rat brain microvessels.

Authors:  W Schütz; G Steurer; E Tuisl
Journal:  Eur J Pharmacol       Date:  1982-11-19       Impact factor: 4.432

Review 7.  Role of endothelium in responses of vascular smooth muscle.

Authors:  R F Furchgott
Journal:  Circ Res       Date:  1983-11       Impact factor: 17.367

8.  Simultaneous analysis of families of sigmoidal curves: application to bioassay, radioligand assay, and physiological dose-response curves.

Authors:  A DeLean; P J Munson; D Rodbard
Journal:  Am J Physiol       Date:  1978-08

9.  Isolation, identification, and continuous culture of coronary endothelial cells from guinea pig hearts.

Authors:  S Nees; A L Gerbes; E Gerlach; J Staubesand
Journal:  Eur J Cell Biol       Date:  1981-06       Impact factor: 4.492

10.  Adenosine analogues stimulate cyclic AMP formation in rabbit cerebral microvessels via adenosine A2-receptors.

Authors:  Y O Li; B B Fredholm
Journal:  Acta Physiol Scand       Date:  1985-06
View more
  15 in total

1.  Purinergic regulation of bradykinin-induced plasma extravasation and adjuvant-induced arthritis in the rat.

Authors:  P G Green; A I Basbaum; C Helms; J D Levine
Journal:  Proc Natl Acad Sci U S A       Date:  1991-05-15       Impact factor: 11.205

Review 2.  Cardiac purinergic signalling in health and disease.

Authors:  Geoffrey Burnstock; Amir Pelleg
Journal:  Purinergic Signal       Date:  2014-12-20       Impact factor: 3.765

3.  Multiple adenosine receptor subtypes stimulate wound healing in human EA.hy926 endothelial cells.

Authors:  Zeinab Bonyanian; Matthew Walker; Eugene Du Toit; Roselyn B Rose'Meyer
Journal:  Purinergic Signal       Date:  2019-06-28       Impact factor: 3.765

4.  Endothelium-mediated coronary dilatation by adenosine does not depend on endothelial adenylate cyclase activation: studies in isolated guinea pig hearts.

Authors:  W H Newman; B F Becker; M Heier; S Nees; E Gerlach
Journal:  Pflugers Arch       Date:  1988-11       Impact factor: 3.657

5.  Evidence that A2 purinoceptors are involved in endothelium-dependent relaxation of the rat thoracic aorta.

Authors:  R B Rose'Meyer; W Hope
Journal:  Br J Pharmacol       Date:  1990-07       Impact factor: 8.739

6.  Effects of adenosine analogues on contractile response and cAMP content in guinea-pig isolated ventricular myocytes.

Authors:  J Neumann; W Schmitz; H Scholz; B Stein
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  1989-12       Impact factor: 3.000

7.  Stimulation of human umbilical vein endothelial cell proliferation by A2-adenosine and beta 2-adrenoceptors.

Authors:  V Sexl; G Mancusi; S Baumgartner-Parzer; W Schütz; M Freissmuth
Journal:  Br J Pharmacol       Date:  1995-04       Impact factor: 8.739

8.  Increases in endothelial cyclic AMP levels amplify agonist-induced formation of endothelium-derived relaxing factor (EDRF).

Authors:  W F Graier; K Groschner; K Schmidt; W R Kukovetz
Journal:  Biochem J       Date:  1992-12-01       Impact factor: 3.857

9.  A2-purinoceptor-mediated relaxation in the guinea-pig coronary vasculature: a role for nitric oxide.

Authors:  A Vials; G Burnstock
Journal:  Br J Pharmacol       Date:  1993-06       Impact factor: 8.739

10.  Adenosine promotes wound healing and mediates angiogenesis in response to tissue injury via occupancy of A(2A) receptors.

Authors:  M Carmen Montesinos; Avani Desai; Jiang-Fan Chen; Herman Yee; Michael A Schwarzschild; J Stephen Fink; Bruce N Cronstein
Journal:  Am J Pathol       Date:  2002-06       Impact factor: 4.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.